Multiple immune-, inflammation-, and infection-related proteins

Multiple immune-, inflammation-, and infection-related proteins refers to a broad and heterogeneous collection of molecular entities that orchestrate the body's response to pathogens, tissue injury, and internal stressors. This group includes diverse molecular classes such as cytokines, chemokines, interferons, and various cell-surface receptors involved in leukocyte signaling (Source: UniProt, GO:0002376). These proteins are fundamental to both innate and adaptive immunity, facilitating cell-to-cell communication and the recruitment of immune cells to sites of infection or damage (Source: PubMed, PMID: 31009102). Pathologically, the dysregulation of these proteins is central to the development of autoimmune diseases, chronic inflammatory conditions, and life-threatening systemic responses like sepsis (Source: NIH, NIAID). Therapeutic intervention often involves the use of biologics to neutralize specific cytokines or small molecules to inhibit downstream signaling pathways like the JAK-STAT cascade (Source: StatPearls). Because this designation represents a functional category rather than a single molecular target, it is typically used in the context of systems biology or broad therapeutic indications rather than specific drug-binding assays. Common biomarkers for monitoring the activity of these proteins include C-reactive protein and various interleukins found in systemic circulation (Source: Mayo Clinic).

Other names

Immune-related proteinsInflammatory mediatorsInfection-related proteinsImmunomodulatory proteins

Modulation of immune signaling cascades through the inhibition of pro-inflammatory mediators, antagonism of cytokine receptors, or suppression of leukocyte activation and recruitment (Source: PubMed, PMID: 28418213).